BRIEF-U.S. FDA approves siliq to treat adults with moderate-to-severe plaque psoriasis
February 15, 2017 at 18:16 PM EST
* U.S. FDA approves siliq (brodalumab) to treat adults with moderate-to-severe plaque psoriasis
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.